Schwab 5AM

@MIHSBoysSoccer Streaming tonight?

Playoffs start tonight, see you there!

@LifeSciVC You’re not alone….

One of the most compelling cold email VC pitches I've ever received... very hard to not feel a strong desire to invest in this startup and back this CEO... Can you imagine how fun Board meetings would be? Wow.

@LifeSciVC “I'm not getting any responses which makes sense when addressing an audience who fails constantly in their job to make profitable investments. However, I will not give up, mainly because somehow despite your less than stellar track record, you have remained in charge of VC.”

Congrats to NE Storm & Phillips Exeter 2025 PG Tyler Bike on winning the NEPSAC Class A Championship. What an amazing season he has had! Tyler was also named Class A Tourney MVP. This young man knows how to win, how to lead, and can flat out play. @NEStormBball @ExeterHoop

2024 CG Osiris Nalls (Philips Exeter) wins the Class A Prep School Championship. They knocked off Philips Andover on Sunday night. Nalls was a starting guard this past season who averaged 17ppg & 4 reb shooting 48% FG - 43 % 3pt FG%

NEW ENGLAND CHAMPIONS!! Boys Basketball captures the fifth Class A title in program history with a 60-42 victory over Andover!! What a day, what a season! #WeAreExeter @NEPSAC

From California: @5amVentures's Andy Schwab shares his take on biotech and his firm's portfolio, including embryo storage company @TMRWLifeSci. Full video: biotechtv.com/post/5am-ventu…

@BelkReport twitter.com/lawyerinthe207…

I need some Mike Loughnane highlights. Someone come through!

When having discussions with VC investors, Scott Platshon, Partner at EcoR1 Capital provides solid advice: “We call it the one bullet point test. Can you communicate the value in one cohesive bullet point? As soon as there’s complexity and nuance, you lose people.” #BiocomGPIC

AstraZeneca has agreed to buy U.S.-listed biopharmaceutical company CinCor Pharma, adding a cardiorenal drug to its portfolio on.wsj.com/3XbY0pq

@debpalestrant @5amVentures @ClaytonCritcher Go team!!

More fun pre #jpm2023 with my fantastic ⁦@5amVentures⁩ team! ⁦@Schwab5AM⁩ ⁦@ClaytonCritcher⁩ David Allison! Looking forward to a great week!

Congratulations! We are excited to have @amyschumer joining the @TMRWLifeSci family! prnewswire.com/news-releases/…

Days after adding some finance, dealmaking and technical talent to the top team, Escient Pharma has taken the wraps off a $120 million round to go broader in the clinic. endpts.com/san-diego-biot…

Happy Halloween from ⁦@5amVentures⁩!!

Please help us welcome Anna Yaeger and Brian Chow, PhD to the 5AM team! globenewswire.com/news-release/2…

Pre board meeting bonding! ⁦@camp4tx⁩ ⁦@J_M_Brehm⁩ ⁦@leonard_zon⁩ and Paula Ragan, Jim Boylan, Michael Higgins.

Welcome to the 5AM team!!

#News: Excited to share we’ve secured $43.5 million in our Series B financing to advance our ongoing Phase 2a clinical trial in #hyperoxaluria and pipeline of #GEMMs candidates for #IBD. Learn more: novomebio.com #celltherapy #livingmedicines

🧵 (1/3) We're excited to announce the closing of our $100 million #SeriesB round. This financing will advance clinical development of our lead #regRNA programs & fuel expansion of our RNA Actuating Platform to upregulate #GeneExpression: ow.ly/3JIm50JZC2l